Clinical Trials on Chronic Obstructive Pulmonary Disease Mild
Total 45693 results
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseNetherlands, Austria, Denmark, Norway, Sweden
-
Barts & The London NHS TrustNational Health Service, United KingdomCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Mahidol UniversityNational Science and Technology Development Agency, ThailandCompletedChronic Obstructive Pulmonary DiseaseThailand
-
University of Nove de JulhoCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
DeyCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
Schön Klinik Berchtesgadener LandCompletedChronic Obstructive Pulmonary DiseaseGermany
-
Villa Pineta HospitalCompletedChronic Obstructive Pulmonary DiseaseItaly
-
National Taiwan University HospitalUnknownChronic Obstructive Pulmonary DiseaseTaiwan
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseItaly, Spain, Sweden
-
University Hospital, AntwerpChiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseBelgium
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseBelgium, France, Japan
-
Fondazione Salvatore MaugeriCompletedChronic Obstructive Pulmonary DiseaseItaly
-
Fondazione Salvatore MaugeriCompletedChronic Obstructive Pulmonary DiseaseItaly
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseGermany, United States, Belgium, Hungary
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseBulgaria, Germany, Hungary, Finland, Slovakia
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States, Spain, Switzerland, France, Italy, Germany, Turkey, Hungary, Norway, Slovakia, Poland, Russian Federation, Canada, Belgium, Austria, Colombia, Denmark, Finland, Greece, Israel, Mexico, United Kingdom
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseSpain, United States, Belgium
-
Laval UniversityCompletedChronic Obstructive Pulmonary DiseaseCanada
-
AstraZenecaQuintiles, Inc.TerminatedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany
-
Ligue Pulmonaire GenevoiseCompletedChronic Obstructive Pulmonary DiseaseSwitzerland
-
Institut National de la Santé Et de la Recherche...Centre Hospitalier Régional Universitaire MontpellierCompletedChronic Obstructive Pulmonary Disease
-
The Korean Academy of Tuberculosis and Respiratory...GlaxoSmithKlineCompletedChronic Obstructive Pulmonary DiseaseKorea, Republic of
-
Policlinico HospitalCompletedChronic Obstructive Pulmonary DiseaseItaly
-
Laval UniversityGlaxoSmithKlineCompletedChronic Obstructive Pulmonary DiseaseCanada
-
Glostrup University Hospital, CopenhagenUnknownChronic Obstructive Pulmonary DiseaseDenmark
-
Imperial College LondonCompletedChronic Obstructive Pulmonary Disease | Idiopathic Pulmonary FibrosisUnited Kingdom
-
University Hospital, Clermont-FerrandUnknownHypoxemia | COPD (Chronic Obstructive Pulmonary Disease)France
-
Aveiro UniversityFundação para a Ciência e a TecnologiaCompletedChronic Obstructive Pulmonary Disease (COPD)Portugal
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknownChronic Respiratory Failure | Chronic Obstructive Pulmonary Disease PatientsItaly
-
Zhujiang HospitalGuangzhou Institute of Respiratory DiseaseUnknownMalnutrition | Chronic Obstructive Pulmonary Disease(COPD)China
-
Inmunotek S.L.Active, not recruitingChronic Obstructive Pulmonary Disease (COPD)Spain
-
Teva Branded Pharmaceutical Products R&D, Inc.WithdrawnChronic Obstructive Pulmonary Disease | COPD
-
National Jewish HealthNational Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Sweden, France, Italy, Spain, Turkey, United Kingdom, Germany, Denmark, Finland, Netherlands, Norway, Austria, Belgium, Portugal, Greece, Ireland, Switzerland
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPDPoland, United Kingdom, Germany, Sweden, Denmark
-
Beaumont HospitalAerogenCompletedChronic Obstructive Pulmonary Disease (COPD)Ireland
-
Sunovion Respiratory Development Inc.CompletedChronic Obstructive Pulmonary Disease | COPDUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Provincial Health Services Authority and other collaboratorsCompletedChronic Obstructive Pulmonary Disease (COPD)Canada
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease | COPDGermany
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Spain, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPDAustria, France, Hungary, Italy, Poland, Portugal, Russian Federation, South Africa, Spain, Canada, United Kingdom, Australia, Netherlands, Switzerland
-
VA Office of Research and DevelopmentCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Banner HealthSanofi Pasteur, a Sanofi CompanyUnknownChronic Obstructive Pulmonary DiseaseUnited States
-
Merck Sharp & Dohme LLCCompletedChronic Obstructive Pulmonary Disease (COPD)
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Hacettepe UniversityAtatürk Chest Diseases and Chest Surgery Training and Research HospitalCompletedChronic Obstructive Pulmonary Disease (COPD)Turkey